眼下，全国启动了道地药材建设布局，以品种为纲、产地为目，定品种、定产地和定标准相结合，优化道地药材生产布局。按照因地制宜、分类指导、突出重点的思路，将全国道地药材基地划分为东北道地药材产区、华北道地药材产区、华东道地药材产区、华中道地药材产区、华南道地药材产区、西南道地药材产区、西北道地药材产区7大区域，到2025年分别建设道地药材生产基地140万亩以上、180万亩以上、280万亩以上、430万亩以上、160万亩以上、670万亩以上、670万亩以上、800万亩以上。
At present, the whole country has launched the construction and layout of genuine medicinal materials, aiming at variety and origin, and combining variety, origin and standard to optimize the production layout of genuine medicinal materials. According to the idea of adapting measures to local conditions, classifying guidance and highlighting key points, the national genuine medicinal material base is divided into seven regions: northeast genuine medicinal material producing area, North China genuine medicinal material producing area, East China genuine medicinal material producing area, central China genuine medicinal material producing area, South China genuine medicinal material producing area, southwest genuine medicinal material producing area and northwest genuine medicinal material producing area, reaching 2 regions. In 2025, the authentic production bases of medicinal materials were constructed over 1.4 million mu, 1.8 million mu, 2.8 million mu, 4.3 million mu, 1.6 million mu, 6.7 million mu and 8 million mu respectively.